BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 16723091)

  • 1. Effect of standard nicotinamide in the prevention of type 1 diabetes in first degree relatives of persons with type 1 diabetes.
    Cabrera-Rode E; Molina G; Arranz C; Vera M; González P; Suárez R; Prieto M; Padrón S; León R; Tillan J; García I; Tiberti C; Rodríguez OM; Gutiérrez A; Fernández T; Govea A; Hernández J; Chiong D; Domínguez E; Di Mario U; Díaz-Díaz O; Díaz-Horta O
    Autoimmunity; 2006 Jun; 39(4):333-40. PubMed ID: 16891222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic Insights into the Multiple Functions of Niacinamide: Therapeutic Implications and Cosmeceutical Applications in Functional Skincare Products.
    Marques C; Hadjab F; Porcello A; Lourenço K; Scaletta C; Abdel-Sayed P; Hirt-Burri N; Applegate LA; Laurent A
    Antioxidants (Basel); 2024 Mar; 13(4):. PubMed ID: 38671873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report: Severe Edema and Marked Weight Gain Induced by Marginal Thiamine Deficiency in a Patient With Alcohol Dependency and Type 2 Diabetes Mellitus.
    Tanaka H; Anno T; Takenouchi H; Iwamoto H; Kaneto H; Okimoto N; Tomoda K
    Front Nutr; 2021; 8():675992. PubMed ID: 34977103
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes.
    Beykin G; Stell L; Halim MS; Nuñez M; Popova L; Nguyen BT; Groth SL; Dennis A; Li Z; Atkins M; Khavari T; Wang SY; Chang R; Fisher AC; Sepah YJ; Goldberg JL
    Am J Ophthalmol; 2022 Feb; 234():223-234. PubMed ID: 34780798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoring T Cell Tolerance, Exploring the Potential of Histone Deacetylase Inhibitors for the Treatment of Juvenile Idiopathic Arthritis.
    Nijhuis L; Peeters JGC; Vastert SJ; van Loosdregt J
    Front Immunol; 2019; 10():151. PubMed ID: 30792714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of C-peptide Alone or in Combination with Nicotinamide on Insulin Levels from Pancreatic Islets in Mouse.
    Ahangarpour A; Ali Akbari FR; Moghadam HF
    Malays J Med Sci; 2016 Jan; 23(1):15-21. PubMed ID: 27540321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of C-peptide Alone or in Combination with Nicotinamide on Glucose and Insulin Levels in Streptozotocin-Nicotinamide-Induced Type 2 Diabetic Mice.
    Ahangarpour A; Ramezani Ali Akbari F; Fathi Moghadam H
    Malays J Med Sci; 2014 Jul; 21(4):12-7. PubMed ID: 25977616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan.
    Kobeissy A; Zantout MS; Azar ST
    Clin Ther; 2008 Aug; 30(8):1408-15. PubMed ID: 18803984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of high-dose nicotinamide: a review.
    Knip M; Douek IF; Moore WP; Gillmor HA; McLean AE; Bingley PJ; Gale EA;
    Diabetologia; 2000 Nov; 43(11):1337-45. PubMed ID: 11126400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nicotinamide on newly diagnosed type 1 diabetic children.
    Kamal M; Abbasy AJ; Muslemani AA; Bener A
    Acta Pharmacol Sin; 2006 Jun; 27(6):724-7. PubMed ID: 16723091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study.
    Pozzilli P; Manfrini S; Buzzetti R; Lampeter E; Leeuw ID; Iafusco D; Prisco M; Ionescu-Tirgoviste C; Kolouskovà S; Linn T; Ludvigsson J; Madàcsy L; Mrozikiewicz AS; Mrozikiewicz PM; Podar T; Vavrinec J; Vialettes B; Visalli N; Yilmaz T; Browne PD;
    Diabetes Res Clin Pract; 2005 Jun; 68(3):258-64. PubMed ID: 15936469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycaemic control with modified intensive insulin injections (MII) using insulin pens and premixed insulin in children with type-1 diabetes: a randomized controlled trial.
    Soliman AT; Omar M; Rizk MM; El Awwa A; AlGhobashy FM
    J Trop Pediatr; 2006 Aug; 52(4):276-81. PubMed ID: 16410276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI).
    Pitocco D; Crinò A; Di Stasio E; Manfrini S; Guglielmi C; Spera S; Anguissola GB; Visalli N; Suraci C; Matteoli MC; Patera IP; Cavallo MG; Bizzarri C; Pozzilli P;
    Diabet Med; 2006 Aug; 23(8):920-3. PubMed ID: 16911633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual B cell activity and insulin requirements in insulin-dependent diabetic patients treated from the beginning with high doses of nicotinamide. A two-year follow-up.
    Taboga C; Tonutti L; Noacco C
    Recenti Prog Med; 1994 Nov; 85(11):513-6. PubMed ID: 7855383
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.